Avidor B, Avidor T, Schwartz L, De Jongh KS, Atlas D (1994). Cardiac L-type Ca 2+ channel triggers transmitter release in PC12 cells. FEBS Lett 342: 209–213.
Bayatti N, Zschocke J, Behl C (2003). Brain region-specific neuroprotective action and signaling of corticotropin-releasing hormone in primary neurons. Endocrinology 144: 4051–4060.
Bean BP (1989). Classes of calcium channels in vertebrate cells. Annu Rev Physiol 51: 367–384.
Brar BK, Jonassen AK, Egorina EM, Chen A, Negro A, Perrin MH et al (2004). Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart. Endocrinology 145: 24–35.
Catterall WA (1995). Structure and function of voltage-gated ion channels. Annu Rev Biochem 64: 493–531.
Catterall WA (1998). Structure and function of neuronal Ca 2+ channels and their role in neurotransmitter release. Cell Calcium 24: 307–323.
Chen A, Blount A, Vaughan J, Brar B, Vale W (2004). Urocortin II gene is highly expressed in mouse skin and skeletal muscle tissues: localization, basal expression in corticotropin-releasing factor receptor (CRFR) 1- and CRFR2-null mice, and regulation by glucocorticoids. Endocrinology 145: 2445–2457.
Day M, Wang Z, Ding J, An X, Ingham CA, Shering AF et al (2006). Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 9: 251–259.
Del Toro R, Levitsky KL, Lopez-Barneo J, Chiara MD (2003). Induction of T-type calcium channel gene expression by chronic hypoxia. J Biol Chem 278: 22316–22324.
Eckert R, Chad J (1984). Inactivation of calcium channels. Prog Biophys Mol Biol 44: 69–125.
Gage MJ, Rane SG, Hockerman GH, Smith TJ (2002). The virally encoded fungal toxin KP4 specifically blocks L-type voltage-gated calcium channels. Mol Pharmacol 61: 936–944.
Hagiwara S, Byerly L (1981). Calcium channel. Annu Rev Neurosci 4: 69–125.
Hsu SY, Hsueh AJ (2001). Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 7: 605–611.
Ikeda K, Tojo K, Otsubo C, Udagawa T, Hosoya T, Tajima N et al (2005). Effects of urocortin II on neonatal rat cardiac myocytes and non-myocytes. Peptides 26: 2473–2481.
Ikeda K, Tojo K, Sato S, Ebisawa T, Tokudome G, Hosoya T et al (1998). Urocortin, a newly identified corticotropin-releasing factor-related mammalian peptide, stimulates atrial natriuretic peptide and brain natriuretic peptide secretions from neonatal rat cardiomyocytes. Biochem Biophys Res Commun 250: 298–304.
Kageyama K, Furukawa K, Miki I, Terui K, Motomura S, Suda T (2003). Vasodilative effects of urocortin II via protein kinase A and a mitogen-activated protein kinase in rat thoracic aorta. J Cardiovasc Pharmacol 42: 561–565.
Kostyuk PG, Verkhratsky A (1994). Calcium stores in neurons and glia. Neuroscience 63: 381–404.
Kostyuk PG, Verkhratsky A (1995). Calcium signaling in the nervous system. John Wiley & Sons Ltd.: Chichester.
Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C et al (2001). Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci 98: 7570–7575.
Lipscombe D, Madison DV, Poenie M, Reuter H, Tsien RW, Tsien RY (1988). Imaging of cytosolic Ca 2+ transients arising from Ca 2+ stores and Ca 2+ channels in sympathetic neurons. Neuron 1: 355–365.
Liu L, Gonzalez PK, Barrett CF, Rittenhouse AR (2003). The calcium channel ligand FPL 64176 enhances L-type but inhibits N-type neuronal calcium currents. Neuropharmacology 45: 281–292.
